Determining the Best Treatment Algorithm for Patients with Head and Neck Cancer

Access Course


1a2ba882-5629-4b61-b437-e21681e56155.jpgExperts discuss treatment strategies for one patient with recurrent HNSCC and one with locally advanced HNSCC.

This activity is intended for oncologists, pathologists, radiologists, surgeons, and other healthcare professionals who manage patients with head and neck cancer.

The goal of this activity is to discuss the emergence of immunotherapy in head and neck cancer along with treatment approaches with both curative and noncurative disease and clinical trials.


Approximate Time to Complete: 35 minutes


Course Available Beginning: Dec. 20, 2016


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the appropriate modalities for patients with head and neck cancer based on factors such as medical history, stage of disease, anatomic site of cancer, human papillomavirus status, and patient preferences
  • Have increased knowledge regarding the clinical trial options for the treatment of head and neck cancer